Post Marketing Surveillance for ADACEL™ in South Korea

Summary

This safety surveillance study is being conducted in accordance with Korea Food and Drug Administration (KFDA) Notification No. 2009-46 "Basic standard for reexamination of new drug". The study objective is to assess within 30 days post-administration, the safety of ADACEL™ administered under the real clinical practice.

Timeline

Start

2010-06

Primary completion

2016-03

Completion

2016-09

Drugs

Indications